Are Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)’s Fundamentals Enough to Outperform
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) Relative Strength Index (RSI) is 61.84, with weekly volatility at 6.72% and ATR at 0.39. The ZYNE stock’s 52-week price range